Language selection

Search

Details for: TEVA-SPIRONOLACTONE/HCTZ

Company: TEVA CANADA LIMITED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
00613231TEVA-SPIRONOLACTONE/HCTZSPIRONOLACTONE; HYDROCHLOROTHIAZIDE25 MG; 25 MGTABLETORAL
00657182TEVA-SPIRONOLACTONE/HCTZSPIRONOLACTONE; HYDROCHLOROTHIAZIDE50 MG; 50 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Hydrochlorothiazide - Assessing the potential risk of non-melanoma skin cancer

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: